AstraZeneca strengthens its vaccine pipeline by acquiring early-stage biotech firm Omniose, which specializes in developing ...
Eli Lilly's Phase 3 trial reveals that its weight-loss pill Foundayo effectively reduces obstructive sleep apnea severity, ...
Zura Bio announces the failure of its experimental drug tibulizumab in a mid-stage trial for treating hidradenitis ...
BDR Pharmaceuticals has acquired a controlling stake in Acme Formulations' oral solid formulations division, enhancing its ...
Mumbai: Drugmaker Lupin Limited ha launched raltegravir tablets in the US, following the approval of its Abbreviated New Drug ...
Boehringer Ingelheim and Zealand Pharma's obesity drug, Survodutide, shows no increased heart risk and significant weight loss in a late-stage trial, paving the way for global regulatory approval.
Divi's Laboratories announces the establishment of new Solid Phase Peptide Synthesis (SPPS) lines to cater to increasing ...
Alembic Pharmaceuticals has received final approval from the US FDA for its Olopatadine Hydrochloride ophthalmic solution, a ...
Morepen Laboratories launches desloratadine, a second-generation antihistamine for allergies, entering the US pharmaceutical ...
India's NPPA caps trade margins on anti-cancer drugs to reduce costs significantly, aiming for annual savings of ₹2,500 crore ...
The FDA has approved Bayer's new blood thinner Sunharbo to prevent recurrent strokes in patients. This innovative treatment ...
The US FDA has mandated new warnings for GLP-1 medications, including Ozempic and Zepbound, regarding a potential eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results